SYNAGIS®

(Palivizumab)

Documentation

Patented
Approved 1998
FDA Letter
FDA Label
Full Sequence

Brief Summary

Function Type: Antagonist
Target: Fprotein(RSV)
Indication Category: Infection

Approved Indications

Detailed Summary

Side Effects

References

Wikipedia
Drugs.com
FDA